Monthly Archives: May 2006

Lowering Blood Pressure Doesn’t Prevent Cognitive Impairment, Dementia

Lowering blood pressure does not appear to prevent cognitive or dementia-related disorders, a desired effect in light of the large number of elderly adults who suffer from both cognitive impairment and hypertension.

Baylor Researchers Develop “bubble” Technique For Potential Treatment Of Type 1 Diabetes

Researchers have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin. This approach is a major step in the potential treatment of Type I diabetes since patients with the disease do not produce enough insulin on their own.

A Non-Invasive Method For Measuring Beta Cell Mass During Diabetes

Serum insulin concentrations provide an imprecise measure of beta cell mass, and no reliable non-invasive measure of beta cell mass has been available, until now.

Study: Certain Blood Pressure-Lowering Drugs Reduce Diabetes Risk In Hispanic Patients

While beta-blockers and diuretics have long been used to treat patients with hypertension, Hispanic patients appear to benefit from a tailor-made strategy that includes other medications, particularly calcium antagonists and angiotensin-converting, or ACE, inhibitors.

Young Adults Are Fastest Growing Group Of Uninsured

Young adults between the ages of 19 and 29 represent the largest and fastest growing segment of the population without health insurance, and are uninsured at twice the rate of adults ages 30 to 64.

Recall: Boca Medical Ultilet and Closercare Insulin Syringes Recalled

Boca Medical Products is initiating a recall of 41 boxes of Closercare Insulin Syringe 29g 1cc product lot number 5JCZ1 as displayed on the inner case and 2320 boxes of Ultilet Insulin Syringe 30g 1/2cc product lot number 5KEO1 as displayed on the inner case.

“Stepped-Up” Care Improves Blood Pressure Control

A new review of evidence suggests that a "stepped-up" care approach can lower blood pressure for patients who haven't achieved good control of their hypertension.

Diabetes, Heart Disease Can Herald Early GI Cancers

Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. Research now also demonstrates that these conditions can be warning signs for some types of digestive cancers.

Study: Widely-Used Nutritional Supplement Does Not Improve Cholesterol Levels

A new study suggests that use of the nutritional supplement policosanol does not lower cholesterol levels any more than placebo, apparently contradicting the results of previous studies.

Study: Cholesterol-Lowering Drugs Not Associated With Increased Breast Cancer Risk

Women who took statins do not face an increased breast cancer risk as had been suggested by some previous studies.

Study: Substances In Grapefruit Juice Interact Dangerously With Some Drugs

New research has identified and established the substance in grapefruit juice that causes potentially dangerous interactions with certain medications.

Study: Nutrients’ Effects On Brain Provides Insight Into Appetite Regulation

A cell-signaling pathway in the brain that is linked to the development of cancer and diabetes is also a key part of networks that regulate food intake.

Survey: Some People Would Give Life or Limb Not To Be Fat

Nearly half of the people responding to an online survey about obesity said they would give up a year of their life rather than be fat.

Study: Signaling Pathways Required for Expansion of Pancreas Stem Cells

IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.

Study: Antidepressant Medication May Prevent Recurring Depression In Diabetics

The antidepressant sertraline may reduce the risk of recurrent depression and increase the period of time between episodes of depression in patients with diabetes.

Study: No Evidence of an Additional Therapeutic Benefit of Inhaled Insulin (Exubera)

There is currently no evidence available that inhaled insulin (Exubera) in diabetes therapy shows advantages over short-acting human insulin or insulin analogues administered subcutaneously.

From the Archive

Other Health News